- not yet recruiting
Vitiligo Registry for Adults and Children in the UK
This study is gathering information on people in the UK with vitiligo, both adults and children. It's creating a big database to better understand the condition, how treatments work, and how safe they are, as there isn't one like this right now.
United Kingdom - active not recruitingPHASE3
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
This study looks at a medicine called ritlecitinib for non-segmental vitiligo, a skin condition causing white patches. It checks how safe and effective the medicine is and if it keeps working or helps more. People who were in an earlier study can join this one.
United States · Australia · Bulgaria - authorisedTherapeutic exploratory (Phase II)
MitOxyVit: Mitochondrial network modulation approach using hyperbaric oxygen (HBO) therapy and NNbUVB for treating vitiligo
This study is looking into new ways to treat vitiligo, a skin condition causing white patches. It combines a special oxygen therapy and light treatment. Researchers want to see if this combination can help repigment the skin and how safe it is over 24 weeks.
France - active not recruitingPHASE3
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
This study looks into a new tablet medicine, upadacitinib, for adults and teenagers with a type of vitiligo. Researchers want to see how safe it is and how well it helps improve skin when compared to a dummy pill or light therapy.
United States · Argentina · Belgium - authorisedTherapeutic exploratory (Phase II)
“A phase 2 multi-center study investigating the efficacy, safety and tolerability of pioglitazone in adult participants with non-segmental vitiligo”
This study is looking into a new use for an existing medicine called pioglitazone for adults with vitiligo. We want to see if this tablet can help improve skin colour and is safe to use. This is an early-stage study to understand its effects better.
Italy - active not recruitingPHASE3
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
This study looks at a new treatment for vitiligo, a condition where patches of skin lose their colour. It compares a special implant (afamelanotide) combined with light therapy (NB-UVB) against light therapy alone, to see how well they work and if they are safe.
United States · France · Kenya